最新发布
Debut and Oterra Join Forces to Replace Red 40 with Precision Fermentation Colors
US biotech company Debut and Danish natural color supplier Oterra have announced a multi-million-dollar collaboration to develop a fermentation-derived alternative to Red 40, one of the most commonly used synthetic food colorings in the United States.
GAI World Summit
Cultivating Connections in Agriculture, Timber, & Natural Capital InvestmentsCultivating Connections in Agriculture, Timber, & Natural Capital Investments
Canada’s Yves Veggie Cuisine Set for Mid-2026 Comeback Under Maple Leaf Foods Ownership
Maple Leaf Foods is set to bring back Yves Veggie Cuisine, one of Canada’s longest-standing plant-based brands, following its acquisition of the label. The relaunch, reported exclusively by Grocery Business through an interview with Adam Grogan, president and COO of Maple Leaf Foods, is targeted for around Canada Day, with six SKUs planned for retail shelves before the end of the year.
ASGCT CEO David Barrett Previews the Upcoming Conference in Boston
The 29th American Society of Gene & Cell Therapy (ASGCT) meeting kicks off in Boston next week. The annual event will be a whirlwind of sessions, keynotes, fireside chats, posters, and exhibitors.
Brisbane, Australia: A Gateway City Powering the Global Agricultural and Food Value Chain
By the Brisbane Economic Development Agency (BEDA)As global agriculture and food investors navigate tightening supply chains, rising input costs, decarbonisation pressures and increasing demand from Asia–Pacific markets, the next generation of agricultural growth hubs is being defined not just by productivity at the farmgate but by their ability to bring together advanced manufacturing, logistics, research and export infrastructure into a unified value chain.
Phytokana Locks In $450M in Customer Contracts Ahead of Faba Protein Facility Launch
Calgary-based faba protein producer Phytokana Ingredients Inc. has signed definitive long-term offtake agreements with a group of domestic and international customers representing approximately $450 million in cumulative contracted revenues. Combined with existing memorandums of understanding, total potential sales exceed $500 million.
ParcelBio Unveils Programmable mRNA Platform Backed by $13M Financing
Biotechnology company ParcelBio said this week that it has raised $13 million in a seed financing round led by Breyer Capital with participation from General Catalyst, Y Combinator, Metaplanet, SurgePoint Capital, ZAKA VC, and other investors. The financing will support the development of the company’s proprietary Amplified and Prolonged EXpression mRNA (APEXm™) platform and advance its pipeline including an in vivo CAR T program for autoimmune disease, as well as additional programs in oncology and encoded protein therapeutics.
BTG Pactual’s Timberland Investment Group Closes Record-Breaking $1.24 Billion Latin American Reforestation Fund
By Staff Writer, Global AgInvesting MediaA milestone for natural capital investing, the BTG Pactual Timberland Investment Group (BTG) has officially closed fundraising for its Latin American Reforestation Strategy, securing a record $1.24 billion in commitments. The announcement, made late April 2026, solidifies the initiative as the largest-known reforestation and restoration fund closed to date.
Gene Therapy Briefs: Regeneron Wins FDA Approval for First Neurosensory Gene Therapy
The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene therapy designed to restore a neurosensory function to normal levels.
Oatly Launches UK’s First Plant-Based Cold Foam for Cafes and Bars
Oatly has introduced Barista Cold Foam to the UK market, a shelf-stable, oat-based topping designed for cold coffee and specialty drinks in foodservice settings. The company says it is the first plant-based cold foam of its kind available in the UK.
